Arginyl-Glutamine (TFA)
Arginyl-Glutamine TFA is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].
Product Specifications
Product Name Alternative
H-Arg-Gln-OH (TFA)
UNSPSC
12352209
Target
VEGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cardiovascular Disease
Purity
99.22
Smiles
N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Molecular Formula
C17H25F9N6O10
Molecular Weight
644.40
References & Citations
[1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
